ℹ️
🇬🇧
Search
Search for publications relevant for "Real-world evidence"
Real-world evidence
Publication
Class
Person
Publication
Programmes
Export current view
publication
Real-Word Evidence: a new standard of medical research?
2017 |
Second Faculty of Medicine
publication
Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic
2024 |
Faculty of Medicine in Pilsen, Third Faculty of Medicine, First Faculty of Medicine
publication
Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe
2020 |
First Faculty of Medicine
publication
Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence
2023 |
First Faculty of Medicine
publication
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
2020 |
Faculty of Medicine in Pilsen
publication
How does the financial market update beliefs about the real economy? Evidence from the oil market
2021 |
Faculty of Social Sciences, Faculty of Mathematics and Physics, Centre for Economic Research and Graduate Education
publication
Lenalidomide maintenance in R2-ISS stratified multiple myeloma patients - real world evidence
Publication without faculty affiliation
publication
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Central Library of Charles University
publication
Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic
2022 |
Second Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Real-world evidence on prognostic value of minimal residual disease in multiple myeloma: Czech experience
Publication without faculty affiliation
publication
Real-World Evidence From More Than 1000 Patients Treated With Adalimumab For Moderate-to-Severe Psoriasis in the Czech Republic
2021 |
Faculty of Medicine in Pilsen, Third Faculty of Medicine, First Faculty of Medicine
publication
Potřebujeme studie z reálné klinické praxe?
2018 |
Second Faculty of Medicine
publication
Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results
2022 |
First Faculty of Medicine
publication
Deintensification to a fixed mixture of insulin glargine and lixisenatide as a way to modern antidiabetic therapy in patients with type 2 diabetes mellitus
2020 |
First Faculty of Medicine
publication
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence
2018 |
Faculty of Medicine in Pilsen
publication
Effect of baseline central retinal thickness on the results of treatment of diabetic macular edema with aflibercept: real-life evidence in the Czech republic
2022 |
Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic
2023 |
Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Central Library of Charles University
publication
Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data
2022 |
Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Central Library of Charles University
publication
Real-world evidence on the dosing and safety of C.E.R.A. in pediatric dialysis patients: findings from the International Pediatric Dialysis Network registries
2024 |
Second Faculty of Medicine
publication
Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech Republic
2019 |
Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Health and economic impact of subcutaneous allergen immunotherapy in patients with pollen-induced allergic rhinoconjunctivitis: real-word evidence from the Czech Republic
2022 |
First Faculty of Medicine
publication
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men
2021 |
First Faculty of Medicine, Central Library of Charles University
publication
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)
2023 |
Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity
2023 |
First Faculty of Medicine
publication
Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs
2019 |
First Faculty of Medicine
publication
Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth Technology
2023 |
First Faculty of Medicine
publication
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries
2023 |
First Faculty of Medicine
publication
Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaboration
2023 |
First Faculty of Medicine
publication
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
2023 |
First Faculty of Medicine
publication
Global reach of over 20 years of experience in the patient-centered Fabry Registry: Advancement of Fabry disease expertise and dissemination of real-world evidence to the Fabry community
2023 |
First Faculty of Medicine